In this ASCO podcast episode, Dr. David Fajgenbaum, American immunologist and author, tells about his involvement in finding a cure for the rare Castleman's disease.
I de mer enn 4300 danske menn som er diagnostisert med prostatakreft årlig, er kastrering en vanlig form for behandling. Kastrering er dermed gjort for omtrent en av tre med prostatakreft, og det er vanligvis gitt av kurativ strålebehandling. Menn som er medisinsk eller kirurgisk kastrert bør systematisk undersøkes for osteoporose og, om nødvendig, behandlet for dette, primært for å forhindre utvikling av osteoporose-relaterte brudd som ellers kan ha alvorlige konsekvenser.
We have seen quite a few interesting results within Merkel cell carcinomas (MCC) patient treatment. New data consolidate the rationale for including immunotherapy as part of standard treatment for patients with MCCs.
X-ray, UVB light, HPV apoptosis inhibition and reduced immunosurveillance can cause NMSC. Also, hereditary disease genes, a number of genotypical and phenotypical traits as well as sunbathing practices, including tanning beds, can increase the risk of cancer.
Limited exposure to ultraviolet radiation is of the utmost importance to reduce the risk of NMSC. Although surgical intervention remains the standard treatment for NMSC, other treatment modalities have been studied and widely used.
The costs of treatment associated with BCCs place a heavy burden on both the patients and the healthcare system. Early and appropriate treatment will make a major contribution to reducing this burden.